Prenatal determination of fetal RHD in maternal plasma: Two-years experience of routine clinical use;Utilisation en routine clinique du génotypage fœtal RHD sur plasma maternel: Bilan de deux ans d'activité

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 5, 2005, Pages 448-453

  Minon, J M ^a   Schaaps, J P ^a   Retz, M C ^a   Dricot, J F ^a   Foidart, J M ^a   Senterre, J M ^a  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Fetal RHD genotype; Maternal plasma; Routine clinical use

Indexed keywords

RHESUS D ANTIBODY;

ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FETUS; GENE AMPLIFICATION; GENOTYPE; HAPLOTYPE; HUMAN; MATERNAL PLASMA; PHENOTYPE; PREGNANCY; PRENATAL PERIOD; PSEUDOGENE; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; TWIN PREGNANCY;

EID: 24144468580     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82852-2     Document Type: Article

References (27)

1. Daniels G. Blood group antibodies in haemolytic disease of the fetus and newborn. In: Hadley A, Soothill P, eds. Alloimmune disorders of pregnancy. Cambridge University Press 2002: 21-40.
2. Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk NM, Cartron JP. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993; 329: 607-10.
3. Lighten AD, Overton TG, Sepulveda W, Warwick RM, Fisk NM, Bennett PR. Accuracy of the prenatal determination of RHD type status by polymerase chain reaction with amniotic cells. Am J Obstet Gynecol 1995; 173: 1183-5.
4. Lo YMD. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem 2000; 46: 1903-5.
5. Avent ND, Finning KM, Martin PG, Soothill P. Prenatal determination of fetal blood groupe status. Vox Sang 2000; 78 (suppl 2): 155-62.
6. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-7.
7. Lo YMD, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non invasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-75.
8. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH. Kinetics of fetal cellular and cell free DNA in the maternal circulation during and after pregnancy: implications for non-invasive prenatal diagnosis. Transfusion 2001; 41: 1524-30.
9. Heid CA, Stevens J, Livak KJ, Williams PM. Real Time quantitative PCR. Genome Res 1996; 6: 986-4.
10. Colin Y, Cherif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP. Genetic basis of the RhD positive and RhD negative blood group polymorphism as determined by Southern analysis. Blood 1991; 78: 2747-52.
11. Westhoff CM. The Rh blood group system in review: a new face for the next decade. Transfusion 2004; 44: 1663-73.
12. Aubin JT, Le Van Kim C, Mouro I, Colin Y, Bignozzi C, Brossard Y et al. Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification. Br J Hematol 1997; 98: 356-64.
13. Ekman GC, Billingsly R, Hessner MJ. Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry. Am J Hematol 2002; 69: 34-40.
14. Okuda H, Kawano M, Iwamoto S, Tanaka M, Seno T, Okubo Y, Kajii E. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997; 100: 373-79.
15. Avent ND. Antenatal genotyping of the blood groups of the fetus. Vox Sang 1998; 74 (suppl 2): 365-74.
16. Minon JM, Senterre JM, Schaaps JP, Foidart JM. Prenatal prediction of fetal Rhesus D status by a multiplex Real-time PCR using cell free fetal DNA in maternal plasma (abstract). Hematologic 2003; 9 (suppl): 128.
17. Minon JM, Senterre JM, Schaaps JP, Foidart JM. Génotypage fœtal RHD sur plasma maternel par PCR multiplex en temps réel (abstract). Transfus Clin Biol 2003; 10 (suppl 1): 108s.
18. Finning KM, Martin PG, Soothill P, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new non invasive fetal RHD genotyping service. Transfusion 2002; 42: 1079-85.
19. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PMK. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-8.
20. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the RhD negative blood group phenotype. Blood 2000; 95: 12-8.
21. Tax M, van Der School E, van Doom R, Douglas-Berger L, van Rhenen DJ, Maaskant-van Wijk PA. RHC and RHc genotyping in different ethnic groups. Transfusion 2002; 42: 634-44.
22. Avent ND. Molecular biology of the Rh blood group system. J Ped Hematol Oncol 2001; 23: 394-402.
23. re partie: physiopathologie. J Gynecol Obstet Biol Reprod 1998; 27: 135-43.
24. Van der School E, Tax M, Rijnders R, de Haas M, Christiaens G. Prenatal typing of the Rh and Kell blood group system Antigens: the edge of a watershed. Transf Med Rev 2003; 17: 31-44.
25. Moïse KJ. Management of Rhesus alloimmunisation in pregnancy. Obstet Gynecol 2002; 100: 600-611.
26. Mari G. Noninvasive diagnosis by doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000; 342: 9-14.
27. Mari G, Detti L, Oz U, Zimmerman R, Duerig P, Stefos T. Accurate prediction of fetal hemoglobin by doppler ultrasonography. Obstet Gynecol 2002; 99: 589-93.